Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 12235

1.

Integrative Model of the Immune Response to a Pulmonary Macrophage Infection: What Determines the Infection Duration?

Go N, Bidot C, Belloc C, Touzeau S.

PLoS One. 2014 Sep 18;9(9):e107818. doi: 10.1371/journal.pone.0107818. eCollection 2014.

PMID:
25233096
[PubMed - as supplied by publisher]
Free Article
2.

The Effects of Vaccination and Immunity on Bacterial Infection Dynamics In Vivo.

Coward C, Restif O, Dybowski R, Grant AJ, Maskell DJ, Mastroeni P.

PLoS Pathog. 2014 Sep 18;10(9):e1004359. doi: 10.1371/journal.ppat.1004359. eCollection 2014 Sep.

PMID:
25233077
[PubMed - as supplied by publisher]
Free Article
3.

Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients.

Bourguignon P, Clément F, Renaud F, Le Bras V, Koutsoukos M, Burny W, Moris P, Lorin C, Collard A, Leroux-Roels G, Roman F, Janssens M, Vandekerckhove L.

J Immunol Methods. 2014 Sep 12. pii: S0022-1759(14)00258-0. doi: 10.1016/j.jim.2014.09.001. [Epub ahead of print]

PMID:
25224748
[PubMed - as supplied by publisher]
4.

Analysis of safety data in children after receiving two doses of ProQuad® (MMRV).

Klopfer SO, Stek JE, Petrecz M, Reisinger KS, Black SB, Goveia MG, Nicholson O, Gardner JL, Grosso AD, Brown ML, Kuter BJ, Schödel FP.

Vaccine. 2014 Sep 11. pii: S0264-410X(14)01225-0. doi: 10.1016/j.vaccine.2014.08.067. [Epub ahead of print]

PMID:
25219563
[PubMed - as supplied by publisher]
5.

Enhanced Mucosal Immune Responses Against Tetanus Toxoid Using Novel Delivery System Comprised of Chitosan-Functionalized Gold Nanoparticles and Botanical Adjuvant: Characterization, Immunogenicity, and Stability Assessment.

Barhate G, Gautam M, Gairola S, Jadhav S, Pokharkar V.

J Pharm Sci. 2014 Sep 12. doi: 10.1002/jps.24161. [Epub ahead of print]

PMID:
25219511
[PubMed - as supplied by publisher]
6.

Non-clinical safety evaluation of single and repeated intramuscular administrations of MAGE-A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys.

Destexhe E, Grosdidier E, Baudson N, Forster R, Gerard C, Garçon N, Segal L.

J Appl Toxicol. 2014 Sep 12. doi: 10.1002/jat.3025. [Epub ahead of print]

PMID:
25219328
[PubMed - as supplied by publisher]
7.

Phosphoglycerate kinase enhanced immunity of the whole cell of Streptococcus agalactiae in tilapia, Oreochromis niloticus.

Wang YT, Huang HY, Tsai MA, Wang PC, Jiang BH, Chen SC.

Fish Shellfish Immunol. 2014 Sep 10. pii: S1050-4648(14)00333-7. doi: 10.1016/j.fsi.2014.09.008. [Epub ahead of print]

PMID:
25218275
[PubMed - as supplied by publisher]
8.

Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches.

Joshi S, Rawat K, Yadav NK, Kumar V, Siddiqi MI, Dube A.

Front Immunol. 2014 Aug 22;5:380. doi: 10.3389/fimmu.2014.00380. eCollection 2014. Review.

PMID:
25202307
[PubMed]
Free PMC Article
9.

Molecular double-check strategy for the identification and characterization of Suid herpesvirus 1.

Wernike K, Beer M, Freuling CM, Klupp B, Mettenleiter TC, Müller T, Hoffmann B.

J Virol Methods. 2014 Sep 6. pii: S0166-0934(14)00339-5. doi: 10.1016/j.jviromet.2014.08.022. [Epub ahead of print]

PMID:
25200377
[PubMed - as supplied by publisher]
10.

Prokaryotic expression and identification of B- and T-cell combined epitopes of Em95 antigen of Echinococcus multilocularis.

Wang H, Zhang F, Ma X, Ma H, Zhu Y, Liu X, Zhu M, Wen H, Ding J.

Int J Clin Exp Pathol. 2014 Jul 15;7(8):5117-22. eCollection 2014.

PMID:
25197385
[PubMed - in process]
Free PMC Article
11.

Efficacy of a formalin-inactivated vaccine against Streptococcus iniae infection in the farmed grouper Epinephelus coioides by intraperitoneal immunization.

Huang HY, Chen YC, Wang PC, Tsai MA, Yeh SC, Liang HJ, Chen SC.

Vaccine. 2014 Sep 2. pii: S0264-410X(14)01162-1. doi: 10.1016/j.vaccine.2014.08.039. [Epub ahead of print]

PMID:
25192808
[PubMed - as supplied by publisher]
12.

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.

Skinner SR, Szarewski A, Romanowski B, Garland SM, Lazcano-Ponce E, Salmerón J, Del Rosario-Raymundo MR, Verheijen RH, Quek SC, da Silva DP, Kitchener H, Fong KL, Bouchard C, Money DM, Ilancheran A, Cruickshank ME, Levin MJ, Chatterjee A, Stapleton JT, Martens M, Quint W, David MP, Meric D, Hardt K, Descamps D, Geeraerts B, Struyf F, Dubin G; for the VIVIANE Study Group.

Lancet. 2014 Sep 1. pii: S0140-6736(14)60920-X. doi: 10.1016/S0140-6736(14)60920-X. [Epub ahead of print]

PMID:
25189358
[PubMed - as supplied by publisher]
13.

Antagonist Models for Treating Persons With Substance use Disorders.

Woody GE.

Curr Psychiatry Rep. 2014 Oct;16(10):489. doi: 10.1007/s11920-014-0489-1.

PMID:
25182514
[PubMed - in process]
14.

Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.

Ann J, Samant M, Rheaume C, Dumas C, Beaulieu E, Morasse A, Mallett C, Hamelin ME, Papadopoulou B, Boivin G.

Vaccine. 2014 Aug 27. pii: S0264-410X(14)01152-9. doi: 10.1016/j.vaccine.2014.08.029. [Epub ahead of print]

PMID:
25173481
[PubMed - as supplied by publisher]
15.

Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus.

Lee JS, Kwon YM, Hwang HS, Lee YN, Ko EJ, Yoo SE, Kim MC, Kim KH, Cho MK, Lee YT, Lee YR, Quan FS, Kang SM.

Vaccine. 2014 Aug 27. pii: S0264-410X(14)01168-2. doi: 10.1016/j.vaccine.2014.08.045. [Epub ahead of print]

PMID:
25173478
[PubMed - as supplied by publisher]
16.

Display of native proteins on Bacillus subtilis spores.

Pan JG, Choi SK, Jung HC, Kim EJ.

FEMS Microbiol Lett. 2014 Aug 4. doi: 10.1111/1574-6968.12558. [Epub ahead of print]

PMID:
25168353
[PubMed - as supplied by publisher]
17.

Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer.

Trajanoski Z, Maccalli C, Mennonna D, Casorati G, Parmiani G, Dellabona P.

Cancer Immunol Immunother. 2014 Aug 28. [Epub ahead of print]

PMID:
25164877
[PubMed - as supplied by publisher]
18.

Structural studies of virus-antibody immune complexes (poliovirus type I): Characterization of the epitopes in 3D.

Bannwarth L, Girerd-Chambaz Y, Arteni AA, Guigner JM, Lemains J, Ronzon F, Manin C, Vénien-Bryan C.

Mol Immunol. 2014 Aug 18. pii: S0161-5890(14)00184-9. doi: 10.1016/j.molimm.2014.07.014. [Epub ahead of print]

PMID:
25146483
[PubMed - as supplied by publisher]
19.

Infection with MERS-CoV causes lethal pneumonia in the common marmoset.

Falzarano D, de Wit E, Feldmann F, Rasmussen AL, Okumura A, Peng X, Thomas MJ, van Doremalen N, Haddock E, Nagy L, LaCasse R, Liu T, Zhu J, McLellan JS, Scott DP, Katze MG, Feldmann H, Munster VJ.

PLoS Pathog. 2014 Aug 21;10(8):e1004250. doi: 10.1371/journal.ppat.1004250. eCollection 2014 Aug.

PMID:
25144235
[PubMed - in process]
Free PMC Article
20.

Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus.

Qiu X, Wong G, Audet J, Cutts T, Niu Y, Booth S, Kobinger GP.

J Virol. 2014 Aug 20. pii: JVI.01643-14. [Epub ahead of print]

PMID:
25142608
[PubMed - as supplied by publisher]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk